Twice-Yearly Lenacapavir Could Support HIV Prevention in Vulnerable Populations. Anderer S. JAMA 2025 Jan 3. doi: 10.1001/jama.2024.26876.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Anderer S. Twice-Yearly Lenacapavir Could Support HIV Prevention in Vulnerable Populations. JAMA 2025 Jan 3. doi: 10.1001/jama.2024.26876.
PMID: 39752151